RSU1P2 and prostate carcinoma: In addition, TCGA data showed that RSU1P2 is high-expression in breast cancer, bladder cancer and prostate cancer (Supplementary Figure S6), it needs to be unraveled whether that RSU1P2 exerts the similar role in these cancer cells.